Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Different Doses of Pramipexole on Subjective and Objective Symptoms of Idiopathic Restless Legs Syndrome (RLS).

NCT00239486 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00239486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00239486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Different Doses of Pramipexole on Subjective and Objective Symptoms of Idiopathic Restless Legs Syndrome (RLS).
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2002
Completion date
April 30, 2004
Enrollment
109
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome